ANNX / Annexon, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Annexon, Inc.
US ˙ NasdaqGS ˙ US03589W1027

Deler fremragende 162,507,278 shares
Insideraktier21.862.142 shares
Insider ejerskab13,45 %
Total Insiders38
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-4 ( )
10520 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.033% ( )
9830 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Annexon, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Dean Richard Artis EVP & CHIEF SCIENTIFIC OFFICER - [O] 180.093 180.093
BCIP Life Sciences Associates, LP 10% Owner - [10%] 3.241.628 5.701.926
Bain Capital Life Sciences Fund, L.P. 10% Owner - [10%] 3.241.628 5.701.926
Bain Capital Life Sciences Investors, LLC 10% Owner - [10%] 5.701.926 5.701.926
Bain Capital Life Sciences Partners, LP 10% Owner - [10%] 3.241.628 5.701.926
Blackstone Clarus III L.L.C. 10% Owner - [10%] 2.730.635 2.730.635
Blackstone Group L.P. 10% Owner - [10%] 2.730.635 2.730.635
Blackstone Group Management L.L.C. 10% Owner - [10%] 2.730.635 2.730.635
Blackstone Holdings I/II GP Inc 10% Owner - [10%] 2.730.635 2.730.635
Blackstone Holdings II L.P. 10% Owner - [10%] 2.730.635 2.730.635
Carson William H. Director - [D] 70.405 70.405
Jung Choi Director - [D] 33.000 33.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Clarus Lifesciences III, L.P. 10% Owner - [10%] 2.730.635 2.730.635
Clarus Ventures III GP, L.P. 10% Owner - [10%] 2.730.635 2.730.635
Cockroft Bettina M. 20.000
Emmett Cunningham 0
Management Co Deerfield 10% Owner - [10%] 808.914 808.914
Deerfield Partners, L.p. 10% Owner - [10%] 808.914 808.914
Jamie Dananberg CHIEF MEDICAL OFFICER - [O] 123.582 123.582
Deerfield Mgmt IV, L.P. 10% Owner - [10%] 808.914 808.914
Deerfield Mgmt L.P. 10% Owner - [10%] 808.914 808.914
Deerfield Private Design Fund IV, L.P. 10% Owner - [10%] 808.914 808.914
James E Flynn 10% Owner - [10%] 808.914 808.914
Carol Giltner Gallagher 0
Jeremy Green 10% Owner - [10%] 1.596.222 1.596.222
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Sanjay Keswani EVP & Chief Medical Officer - [O] 12.500 12.500
Adam Koppel 10% Owner - [10%] 3.241.628 3.241.628
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER - [O] 170.700 170.700
Douglas Love PRESIDENT AND CEO, Director - [D] [O] 351.554 351.554
Larry Mattheakis EVP & Chief Scientific Officer - [O] 17.188 17.188
Michael Overdorf EVP & CHIEF BUSINESS OFFICER - [O] 182.625 182.625
Redmile Group, LLC 10% Owner - [10%] 1.596.222 1.596.222
Stephen A Schwarzman 10% Owner - [10%] 2.730.635 2.730.635
Muneer A Satter Director - [D] 9.728.637 9.728.637
Jeffrey Lawrence Schwartz 10% Owner - [10%] 3.241.628 3.241.628
Ricky Sun 0
Waddill William D. 20.000
Ted Yednock EVP & CHIEF INNOVATION OFFICER - [O] 154.161 154.161

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ANNX / Annexon, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-12-01 Choi Jung 33.000 4,1900 33.000 4,1900 138.270 52 6.9600 91.410 66,11
2025-11-21 Satter Muneer A 422.613 4,2800 422.613 4,2800 1.808.784
2025-11-20 Satter Muneer A 400.000 4,4800 400.000 4,4800 1.792.000
2025-11-19 Satter Muneer A 500.000 3,9400 500.000 3,9400 1.970.000
2025-11-18 Satter Muneer A 500.000 3,1800 500.000 3,1800 1.590.000
2025-11-17 Satter Muneer A 500.000 2,9900 500.000 2,9900 1.495.000
2023-12-26 Satter Muneer A 350.000 2,8800 350.000 2,8800 1.008.000
2023-05-25 Bain Capital Life Sciences Investors, LLC 300.000 2,1324 300.000 2,1324 639.720
2023-02-10 Satter Muneer A 2.647.058 6,8000 2.647.058 6,8000 17.999.994

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANNX / Annexon, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ANNX / Annexon, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-03-02 Lew Jennifer 5.565 5,4200 5.565 5,4200 30.162 28 4.9600 -2.560 -8,49
2026-03-02 Dananberg Jamie 5.820 5,4300 5.820 5,4300 31.603
2026-03-02 Yednock Ted 5.566 5,4200 5.566 5,4200 30.168
2026-03-02 Overdorf Michael 4.339 5,4200 4.339 5,4200 23.517
2026-03-02 ARTIS DEAN RICHARD 5.894 5,4300 5.894 5,4300 32.004
2026-02-18 Dananberg Jamie 5.290 5,1000 5.290 5,1000 26.979
2026-02-18 Lew Jennifer 7.851 5,1100 7.851 5,1100 40.119
2026-02-18 ARTIS DEAN RICHARD 5.290 5,1000 5.290 5,1000 26.979
2026-02-18 Yednock Ted 7.857 5,1100 7.857 5,1100 40.149

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANNX / Annexon, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-14 2026-04-10 4 Carson William H. ANNX Common Stock P - Purchase D 6,2000 8.000 50 70.405
2026-03-12 2026-03-10 4 Carson William H. ANNX Common Stock P - Purchase D 5,6700 8.000 45 62.405
2026-03-04 2026-03-02 4 Lew Jennifer ANNX Common Stock S - Sale D 5,4200 -5.565 -30 170.700
2026-03-04 2026-03-02 4 ARTIS DEAN RICHARD ANNX Common Stock S - Sale D 5,4300 -5.894 -32 180.093
2026-03-04 2026-03-02 4 Yednock Ted ANNX Common Stock S - Sale D 5,4200 -5.566 -30 154.161
2026-03-04 2026-03-02 4 Overdorf Michael ANNX Common Stock S - Sale D 5,4200 -4.339 -24 182.625
2026-03-04 2026-03-02 4 Dananberg Jamie ANNX Common Stock S - Sale D 5,4300 -5.820 -32 123.582
2026-02-23 2026-02-19 4 Dananberg Jamie ANNX Common Stock A - Award D 56.250 129.402
2026-02-23 2026-02-19 4 Overdorf Michael ANNX Common Stock A - Award D 62.500 186.964
2026-02-23 2026-02-19 4 ARTIS DEAN RICHARD ANNX Common Stock A - Award D 62.500 185.987
2026-02-23 2026-02-19 4 Yednock Ted ANNX Common Stock A - Award D 62.500 159.727
2026-02-23 2026-02-19 4 Lew Jennifer ANNX Common Stock A - Award D 62.500 176.265
2026-02-20 2026-02-18 4 Overdorf Michael ANNX Common Stock S - Sale D 5,1000 -6.225 -32 124.464
2026-02-20 2026-02-18 4 Yednock Ted ANNX Common Stock S - Sale D 5,1100 -7.857 -40 97.227
2026-02-20 2026-02-18 4 ARTIS DEAN RICHARD ANNX Common Stock S - Sale D 5,1000 -5.290 -27 123.487
2026-02-20 2026-02-18 4 Lew Jennifer ANNX Common Stock S - Sale D 5,1100 -7.851 -40 113.765
2026-02-20 2026-02-18 4 Dananberg Jamie ANNX Common Stock S - Sale D 5,1000 -5.290 -27 73.152
2026-01-02 2025-12-30 4 Carson William H. ANNX Common Stock P - Purchase D 5,0200 4.115 21 54.405
2025-12-03 2025-12-01 4 Carson William H. ANNX Common Stock P - Purchase D 4,4700 4.115 18 50.290
2025-12-03 2025-12-01 4 Choi Jung By Trust ANNX Common Stock P - Purchase I 4,1900 33.000 138 33.000
2025-11-21 2025-11-21 4 Satter Muneer A ANNX Common Stock P - Purchase I 4,2800 422.613 1.809 9.728.637
2025-11-21 2025-11-20 4 Satter Muneer A ANNX Common Stock P - Purchase I 4,4800 400.000 1.792 9.306.024
2025-11-19 2025-11-19 4 Satter Muneer A ANNX Common Stock P - Purchase I 3,9400 500.000 1.970 8.906.024
2025-11-19 2025-11-18 4 Satter Muneer A ANNX Common Stock P - Purchase I 3,1800 500.000 1.590 8.406.024
2025-11-19 2025-11-17 4 Satter Muneer A ANNX Common Stock P - Purchase I 2,9900 500.000 1.495 7.906.024
2025-10-31 2025-10-30 4 Carson William H. ANNX Common Stock P - Purchase D 3,1700 4.115 13 46.175
2025-10-02 2025-09-30 4 Carson William H. ANNX Common Stock P - Purchase D 3,0500 4.115 13 42.060
2025-09-04 2025-09-02 4 Carson William H. ANNX Common Stock P - Purchase D 2,0900 4.115 9 37.945
2025-08-01 2025-07-30 4 Carson William H. ANNX Common Stock P - Purchase D 2,4300 4.115 10 33.830
2025-07-16 2025-07-14 4 Overdorf Michael ANNX Common Stock S - Sale D 2,6100 -853 -2 130.689
2025-07-16 2025-07-14 4 Lew Jennifer ANNX Common Stock S - Sale D 2,5800 -1.117 -3 121.616
2025-07-16 2025-07-14 4 Yednock Ted ANNX Common Stock S - Sale D 2,5800 -1.116 -3 105.084
2025-07-01 2025-06-30 4 Carson William H. ANNX Common Stock P - Purchase D 2,4600 4.115 10 29.715
2025-03-03 2024-02-27 4 ARTIS DEAN RICHARD ANNX Common Stock A - Award D 44.963 128.777
2025-03-03 2024-02-27 4 Dananberg Jamie ANNX Common Stock A - Award D 44.963 78.442
2025-03-03 2024-02-27 4 Lew Jennifer ANNX Common Stock A - Award D 44.963 122.733
2025-03-03 2024-02-27 4 Yednock Ted ANNX Common Stock A - Award D 44.963 106.200
2025-03-03 2024-02-27 4 Overdorf Michael ANNX Common Stock A - Award D 44.963 131.542
2025-02-20 2025-02-18 4 Dananberg Jamie ANNX Common Stock S - Sale D 2,9600 -5.521 -16 33.479
2025-02-20 2025-02-18 4 ARTIS DEAN RICHARD ANNX Common Stock S - Sale D 2,9700 -5.515 -16 83.814
2025-02-20 2025-02-18 4 Yednock Ted ANNX Common Stock S - Sale D 2,9100 -8.345 -24 61.237
2025-02-20 2025-02-18 4 Overdorf Michael ANNX Common Stock S - Sale D 2,9500 -6.618 -20 86.579
2025-02-20 2025-02-18 4 Lew Jennifer ANNX Common Stock S - Sale D 2,9200 -6.912 -20 77.770
2025-02-18 2025-02-13 4 Yednock Ted ANNX Common Stock S - Sale D 2,9900 -1.783 -5 69.582
2025-02-18 2025-02-13 4 Overdorf Michael ANNX Common Stock S - Sale D 2,9900 -1.425 -4 93.197
2025-02-18 2025-02-13 4 Lew Jennifer ANNX Common Stock S - Sale D 2,9800 -1.786 -5 84.682
2025-02-18 2025-02-13 4 Love Douglas ANNX Common Stock S - Sale D 2,9500 -5.021 -15 351.554
2025-01-08 2025-01-06 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 37.994 54 356.575
2024-12-04 2024-12-02 4 Carson William H. ANNX Common Stock P - Purchase D 5,3300 3.200 17 25.600
2024-11-01 2024-10-30 4 Love Douglas ANNX Common Stock M - Exercise D 1,8501 36.050 67 310.570
2024-11-01 2024-10-30 4 Love Douglas ANNX Common Stock M - Exercise D 1,8501 78.399 145 274.520
2024-10-17 2024-10-15 4 Yednock Ted ANNX Common Stock S - Sale D 7,4100 -5.408 -40 71.365
2024-10-17 2024-10-15 4 Yednock Ted ANNX Common Stock M - Exercise D 1,8501 5.408 10 76.773
2024-10-02 2024-10-01 4 Carson William H. ANNX Common Stock P - Purchase D 5,9700 3.200 19 22.400
2024-09-20 2024-09-19 4 Yednock Ted By Spouse ANNX Common Stock S - Sale I 7,1000 -4.500 -32 0
2024-09-16 2024-09-12 4 Yednock Ted By Spouse ANNX Common Stock S - Sale I 6,1600 -5.500 -34 4.500
2024-09-06 2024-09-05 4 Yednock Ted By Spouse ANNX Common Stock S - Sale I 5,6400 -5.500 -31 10.000
2024-09-04 2024-09-03 4 Carson William H. ANNX Common Stock P - Purchase D 5,4800 3.200 18 19.200
2024-08-30 2024-08-29 4 Yednock Ted By Spouse ANNX Common Stock S - Sale I 5,9500 -5.500 -33 15.500
2024-08-05 2024-08-01 4 Carson William H. ANNX Common Stock P - Purchase D 6,2400 3.200 20 16.000
2024-07-17 2024-07-15 4 Overdorf Michael ANNX Common Stock S - Sale D 6,0200 -784 -5 94.622
2024-07-17 2024-07-15 4 Lew Jennifer ANNX Common Stock S - Sale D 6,0300 -1.104 -7 86.468
2024-07-17 2024-07-15 4 Yednock Ted ANNX Common Stock S - Sale D 6,0200 -1.106 -7 71.365
2024-07-02 2024-07-01 4 Carson William H. ANNX Common Stock P - Purchase D 5,0000 3.200 16 12.800
2024-06-05 2024-06-03 4 Carson William H. ANNX Common Stock P - Purchase D 4,8310 3.200 15 9.600
2024-05-03 2024-05-01 4 Carson William H. ANNX Common Stock P - Purchase D 4,6820 3.200 15 6.400
2024-04-10 2024-04-08 4 Carson William H. ANNX Common Stock P - Purchase D 6,0660 3.200 19 3.200
2024-02-21 2024-02-20 4 Overdorf Michael ANNX Common Stock S - Sale D 5,4800 -1.951 -11 85.641
2024-02-21 2024-02-16 4 Overdorf Michael ANNX Common Stock A - Award D 39.000 87.592
2024-02-21 2024-02-16 4 Dananberg Jamie ANNX Common Stock A - Award D 39.000 39.000
2024-02-21 2024-02-20 4 Yednock Ted ANNX Common Stock S - Sale D 5,5100 -2.604 -14 72.471
2024-02-21 2024-02-16 4 Yednock Ted ANNX Common Stock A - Award D 39.000 75.075
2024-02-21 2024-02-16 4 ARTIS DEAN RICHARD ANNX Common Stock A - Award D 39.000 89.329
2024-02-21 2024-02-20 4 Lew Jennifer ANNX Common Stock S - Sale D 5,5300 -2.593 -14 82.058
2024-02-21 2024-02-16 4 Lew Jennifer ANNX Common Stock A - Award D 39.000 84.651
2024-02-14 2024-02-12 4 Overdorf Michael ANNX Common Stock S - Sale D 5,5300 -1.349 -7 48.592
2024-02-14 2024-02-12 4 Love Douglas ANNX Common Stock S - Sale D 5,5400 -5.782 -32 196.121
2024-02-14 2024-02-12 4 Lew Jennifer ANNX Common Stock S - Sale D 5,5400 -1.809 -10 45.651
2024-02-14 2024-02-12 4 Yednock Ted ANNX Common Stock S - Sale D 5,5400 -1.810 -10 36.075
2024-01-23 2023-12-27 4/A Yednock Ted ANNX Common Stock S - Sale D 4,5222 -21.000 -95 37.885
2024-01-23 2023-12-27 4/A Yednock Ted ANNX Common Stock M - Exercise D 1,8501 10.385 19 58.885
2024-01-23 2023-12-27 4/A Yednock Ted ANNX Common Stock M - Exercise D 1,4096 10.615 15 48.500
2024-01-23 2023-07-11 4/A Yednock Ted ANNX Common Stock S - Sale D 3,8361 -1.057 -4 37.885
2024-01-23 2023-07-11 4 Overdorf Michael ANNX Common Stock S - Sale D 3,8361 -978 -4 45.802
2024-01-23 2023-07-11 4 Lew Jennifer ANNX Common Stock S - Sale D 3,8361 -1.057 -4 47.460
2023-12-29 2023-12-27 4 Yednock Ted ANNX Common Stock S - Sale D 4,5222 -21.000 -95 0
2023-12-29 2023-12-27 4 Yednock Ted ANNX Common Stock M - Exercise D 1,8501 10.385 19 21.000
2023-12-29 2023-12-27 4 Yednock Ted ANNX Common Stock M - Exercise D 1,4096 10.615 15 10.615
2023-12-28 2023-12-26 4 Satter Muneer A ANNX Common Stock P - Purchase I 2,8800 350.000 1.008 7.406.024
2023-05-30 2023-05-25 4 Bain Capital Life Sciences Investors, LLC See footnotes ANNX Common Stock P - Purchase I 2,1324 300.000 640 5.701.926
2023-05-30 3 BCIP Life Sciences Associates, LP ANNX Common Stock I 5.401.926
2023-03-27 3 Yednock Ted ANNX Common Stock D 38.942
2023-03-27 3 Yednock Ted By Spouse ANNX Common Stock I 21.000
2023-02-21 2023-02-16 4 Lew Jennifer ANNX Common Stock A - Award D 18.975 48.517
2023-02-21 2023-02-16 4 Overdorf Michael ANNX Common Stock A - Award D 18.975 46.780
2023-02-17 2023-02-15 4 Love Douglas ANNX Common Stock S - Sale D 5,8688 -6.571 -39 197.646
2023-02-15 2023-02-14 4 Overdorf Michael ANNX Common Stock S - Sale D 6,2993 -144 -1 27.805
2023-02-15 2023-02-13 4 Overdorf Michael ANNX Common Stock S - Sale D 6,3032 -1.501 -9 27.949
2023-02-15 2023-02-14 4 Lew Jennifer ANNX Common Stock S - Sale D 6,3030 -166 -1 29.542
2023-02-15 2023-02-13 4 Lew Jennifer ANNX Common Stock S - Sale D 6,3081 -1.742 -11 29.708
2023-02-14 2023-02-10 4 Satter Muneer A ANNX Common Stock P - Purchase I 6,8000 2.647.058 18.000 7.056.024
2023-01-12 3 ARTIS DEAN RICHARD ANNX Common Stock D 50.329
2022-07-13 2022-07-11 4 Overdorf Michael ANNX Common Stock A - Award D 9.375 21.875
2022-07-13 2022-07-11 4 Mattheakis Larry ANNX Common Stock A - Award D 4.688 17.188
2022-07-13 2022-07-11 4 Mattheakis Larry ANNX Common Stock A - Award D 4.688 17.188
2022-07-13 2022-07-11 4 Lew Jennifer ANNX Common Stock A - Award D 9.375 23.875
2022-07-11 2022-07-07 4 Satter Muneer A ANNX Common Stock P - Purchase I 3,8400 2.453.988 9.423 4.408.966
2022-04-18 2022-04-14 4 Love Douglas ANNX Common Stock P - Purchase D 2,4469 60.000 147 200.942
2022-02-15 2022-02-11 4 Love Douglas ANNX Stock Option (Right to Buy) A - Award D 6,94 320.000 320.000
2022-02-15 2022-02-11 4 Love Douglas ANNX Common Stock A - Award D 40.000 140.942
2022-02-15 2022-02-11 4 Overdorf Michael ANNX Stock Option (Right to Buy) A - Award D 6,94 100.000 100.000
2022-02-15 2022-02-11 4 Overdorf Michael ANNX Common Stock A - Award D 12.500 12.500
2022-02-15 2022-02-11 4 Keswani Sanjay ANNX Stock Option (Right to Buy) A - Award D 6,94 100.000 100.000
2022-02-15 2022-02-11 4 Keswani Sanjay ANNX Common Stock A - Award D 12.500 12.500
2022-02-15 2022-02-11 4 Mattheakis Larry ANNX Stock Option (Right to Buy) A - Award D 6,94 100.000 100.000
2022-02-15 2022-02-11 4 Mattheakis Larry ANNX Common Stock A - Award D 12.500 12.500
2022-02-15 2022-02-11 4 Lew Jennifer ANNX Stock Option (Right to Buy) A - Award D 6,94 100.000 100.000
2022-02-15 2022-02-11 4 Lew Jennifer ANNX Common Stock A - Award D 12.500 14.500
2022-01-20 2022-01-19 4 Cockroft Bettina M. ANNX Stock Option (Right to Buy) A - Award D 8,08 20.000 20.000
2021-11-15 2021-11-11 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,85 -30.000 114.449
2021-11-15 2021-11-11 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -70.942 0
2021-11-15 2021-11-11 4 Love Douglas ANNX Common Stock M - Exercise D 1,8501 30.000 56 100.942
2021-11-15 2021-11-11 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 70.942 100 70.942
2021-10-04 2021-09-30 4 Mattheakis Larry ANNX Stock Option (Right to Buy) A - Award D 18,61 220.000 220.000
2021-09-20 2021-09-16 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -7.500 37.994
2021-09-20 2021-09-16 4 Love Douglas ANNX Common Stock S - Sale D 22,0454 -7.500 -165 0
2021-09-20 2021-09-16 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 7.500 11 7.500
2021-09-15 2021-09-13 4 Yednock Ted ANNX Stock Option (Right to Buy) M - Exercise D 5,11 -1.190 67.939
2021-09-15 2021-09-13 4 Yednock Ted ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -15.000 10.615
2021-09-15 2021-09-13 4 Yednock Ted ANNX Common Stock S - Sale D 20,0037 -16.190 -324 0
2021-09-15 2021-09-13 4 Yednock Ted ANNX Common Stock M - Exercise D 5,1098 1.190 6 16.190
2021-09-15 2021-09-13 4 Yednock Ted ANNX Common Stock M - Exercise D 1,4096 15.000 21 15.000
2021-09-15 2021-09-13 4 Lew Jennifer ANNX Stock Option (Right to Buy) M - Exercise D 7,49 -3.500 143.793
2021-09-15 2021-09-13 4 Lew Jennifer ANNX Common Stock S - Sale D 20,0096 -3.500 -70 2.000
2021-09-15 2021-09-13 4 Lew Jennifer ANNX Common Stock M - Exercise D 7,4885 3.500 26 5.500
2021-08-16 2021-08-12 4 Waddill William D. ANNX Stock Option (Right to Buy) A - Award D 19,73 20.000 20.000
2021-06-09 2021-06-08 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -3.750 45.494
2021-06-09 2021-06-08 4 Love Douglas ANNX Common Stock S - Sale D 22,5500 -3.750 -85 0
2021-06-09 2021-06-08 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 3.750 5 3.750
2021-06-09 2021-06-07 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -3.750 49.244
2021-06-09 2021-06-07 4 Love Douglas ANNX Common Stock S - Sale D 22,3113 -3.750 -84 0
2021-06-09 2021-06-07 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 3.750 5 3.750
2021-06-07 2021-06-03 4 Yednock Ted ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -15.000 25.615
2021-06-07 2021-06-03 4 Yednock Ted ANNX Common Stock S - Sale D 21,7220 -2.184 -47 0
2021-06-07 2021-06-03 4 Yednock Ted ANNX Common Stock S - Sale D 21,4485 -12.816 -275 2.184
2021-06-07 2021-06-03 4 Yednock Ted ANNX Common Stock M - Exercise D 1,4096 15.000 21 15.000
2021-06-04 2021-06-02 4 Satter Muneer A ANNX Stock Option (Right to Buy) A - Award D 21,03 10.000 10.000
2021-06-04 2021-06-02 4 Choi Jung ANNX Stock Option (Right to Buy) A - Award D 21,03 10.000 10.000
2021-06-04 2021-06-02 4 WIGGANS THOMAS G ANNX Stock Option (Right to Buy) A - Award D 21,03 10.000 10.000
2021-06-04 2021-06-02 4 Carson William H. ANNX Stock Option (Right to Buy) A - Award D 21,03 10.000 10.000
2021-06-04 2021-06-02 4 Sun Ricky ANNX Stock Option (Right to Buy) A - Award D 21,03 10.000 10.000
2021-06-01 2021-05-27 4 Lew Jennifer ANNX Stock Option (Right to Buy) M - Exercise D 7,49 -3.500 147.293
2021-06-01 2021-05-27 4 Lew Jennifer ANNX Common Stock S - Sale D 22,2386 -3.500 -78 2.000
2021-06-01 2021-05-27 4 Lew Jennifer ANNX Common Stock M - Exercise D 7,4885 3.500 26 5.500
2021-04-02 2021-04-01 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -500 52.994
2021-04-02 2021-04-01 4 Love Douglas ANNX Common Stock S - Sale D 28,0100 -300 -8 0
2021-04-02 2021-04-01 4 Love Douglas ANNX Common Stock S - Sale D 28,1900 -200 -6 300
2021-04-02 2021-04-01 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 500 1 500
2021-04-02 2021-03-31 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -7.102 53.494
2021-04-02 2021-03-31 4 Love Douglas ANNX Common Stock S - Sale D 28,1077 -7.102 -200 0
2021-04-02 2021-03-31 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 7.102 10 7.102
2021-03-31 2021-03-30 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -3.750 60.596
2021-03-31 2021-03-30 4 Love Douglas ANNX Common Stock S - Sale D 24,7843 -1.850 -46 0
2021-03-31 2021-03-30 4 Love Douglas ANNX Common Stock S - Sale D 24,2711 -1.900 -46 1.850
2021-03-31 2021-03-30 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 3.750 5 3.750
2021-03-31 2021-03-29 4 Love Douglas ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -3.750 64.346
2021-03-31 2021-03-29 4 Love Douglas ANNX Common Stock S - Sale D 27,2383 -300 -8 0
2021-03-31 2021-03-29 4 Love Douglas ANNX Common Stock S - Sale D 26,4184 -600 -16 300
2021-03-31 2021-03-29 4 Love Douglas ANNX Common Stock S - Sale D 25,0216 -2.850 -71 900
2021-03-31 2021-03-29 4 Love Douglas ANNX Common Stock M - Exercise D 1,4096 3.750 5 3.750
2021-03-29 2021-03-25 4 Yednock Ted ANNX Stock Option (Right to Buy) M - Exercise D 5,11 -1.175 69.129
2021-03-29 2021-03-25 4 Yednock Ted ANNX Stock Option (Right to Buy) M - Exercise D 1,41 -15.000 40.615
2021-03-29 2021-03-25 4 Yednock Ted ANNX Common Stock S - Sale D 29,9600 -237 -7 0
2021-03-29 2021-03-25 4 Yednock Ted ANNX Common Stock S - Sale D 29,2102 -5.680 -166 237
2021-03-29 2021-03-25 4 Yednock Ted ANNX Common Stock S - Sale D 28,5392 -10.258 -293 5.917
2021-03-29 2021-03-25 4 Yednock Ted ANNX Common Stock M - Exercise D 5,1098 1.175 6 16.175
2021-03-29 2021-03-25 4 Yednock Ted ANNX Common Stock M - Exercise D 1,4096 15.000 21 15.000
2021-03-26 2021-03-24 4 Keswani Sanjay ANNX Stock Option (Right to Buy) M - Exercise D 7,49 -3.995 182.956
2021-03-26 2021-03-24 4 Keswani Sanjay ANNX Common Stock S - Sale D 30,1657 -3.995 -121 0
2021-03-26 2021-03-24 4 Keswani Sanjay ANNX Common Stock M - Exercise D 7,4885 3.995 30 3.995
2021-03-25 2021-03-23 4 Lew Jennifer ANNX Stock Option (Right to Buy) M - Exercise D 7,49 -5.000 150.793
2021-03-25 2021-03-23 4 Lew Jennifer ANNX Common Stock S - Sale D 29,1629 -1.800 -52 2.000
2021-03-25 2021-03-23 4 Lew Jennifer ANNX Common Stock S - Sale D 28,4304 -1.800 -51 3.800
2021-03-25 2021-03-23 4 Lew Jennifer ANNX Common Stock S - Sale D 27,5061 -1.400 -39 5.600
2021-03-25 2021-03-23 4 Lew Jennifer ANNX Common Stock M - Exercise D 7,4885 5.000 37 7.000
2021-03-01 2021-02-25 4 Yednock Ted ANNX Stock Option (Right to Buy) A - Award D 30,07 115.000 115.000
2021-03-01 2021-02-25 4 Keswani Sanjay ANNX Stock Option (Right to Buy) A - Award D 30,07 115.000 115.000
2021-03-01 2021-02-25 4 Lew Jennifer ANNX Stock Option (Right to Buy) A - Award D 30,07 115.000 115.000
2021-03-01 2021-02-25 4 Overdorf Michael ANNX Stock Option (Right to Buy) A - Award D 30,07 115.000 115.000
2021-03-01 2021-02-25 4 Love Douglas ANNX Stock Option (Right to Buy) A - Award D 30,07 325.000 325.000
2021-02-08 2021-02-05 4 Carson William H. ANNX Stock Option (Right to Buy) A - Award D 24,34 20.000 20.000
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Series D Redeemable Convertible Preferred Stock C - Conversion I -2.109.407 0
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Series C Redeemable Convertible Preferred Stock C - Conversion I -6.148.147 0
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Series B Redeemable Convertible Preferred Stock C - Conversion I -8.370.685 0
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Series A-1 Redeemable Convertible Preferred Stock C - Conversion I -5.666.667 0
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Common Stock P - Purchase I 17,0000 200.000 3.400 2.730.635
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Common Stock C - Conversion I 239.433 2.530.635
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Common Stock C - Conversion I 697.860 2.291.202
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Common Stock C - Conversion I 950.134 1.593.342
2020-07-30 2020-07-28 4 Clarus Lifesciences III, L.P. See Footnotes ANNX Common Stock C - Conversion I 643.208 643.208
2020-07-30 2020-07-28 4 Redmile Group, LLC ANNX Series D Redeemable Convertible Preferred Stock C - Conversion I -14.062.719 0
2020-07-30 2020-07-28 4 Redmile Group, LLC ANNX Common Stock C - Conversion I 1.596.222 1.596.222
2020-07-28 2020-07-28 4 Flynn James E Through Deerfield Partners, L.P. ANNX Series D Preferred Stock C - Conversion I -4.043.031 0
2020-07-28 2020-07-28 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. ANNX Series D Preferred Stock C - Conversion I -4.043.032 0
2020-07-28 2020-07-28 4 Flynn James E Through Deerfield Partners, L.P. ANNX Common Stock P - Purchase I 17,0000 350.000 5.950 808.914
2020-07-28 2020-07-28 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. ANNX Common Stock P - Purchase I 17,0000 350.000 5.950 808.914
2020-07-28 2020-07-28 4 Flynn James E Through Deerfield Partners, L.P. ANNX Common Stock C - Conversion I 458.914 458.914
2020-07-28 2020-07-28 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. ANNX Common Stock C - Conversion I 458.914 458.914
2020-07-28 2020-07-28 4 Satter Muneer A ANNX Series D Preferred Stock C - Conversion I -2.812.543 0
2020-07-28 2020-07-28 4 Satter Muneer A ANNX Series C Preferred Stock C - Conversion I -5.537.036 0
2020-07-28 2020-07-28 4 Satter Muneer A ANNX Series B Preferred Stock C - Conversion I -4.016.573 0
2020-07-28 2020-07-28 4 Satter Muneer A ANNX Series A-1 Preferred Stock C - Conversion I -3.095.238 0
2020-07-28 2020-07-28 4 Satter Muneer A ANNX Common Stock P - Purchase I 17,0000 200.000 3.400 1.954.978
2020-07-28 2020-07-28 4 Satter Muneer A ANNX Common Stock C - Conversion I 1.754.978 1.754.978
2020-07-28 2020-07-28 4 Lew Jennifer ANNX Common Stock P - Purchase D 17,0000 2.000 34 2.000
2020-07-28 2020-07-28 4 Bain Capital Life Sciences Investors, LLC See Footnotes ANNX Series D Preferred Stock C - Conversion I -2.812.543 0
2020-07-28 2020-07-28 4 Bain Capital Life Sciences Investors, LLC See Footnotes ANNX Series C Preferred Stock C - Conversion I -22.222.221 0
2020-07-28 2020-07-28 4 Bain Capital Life Sciences Investors, LLC See Footnotes ANNX Common Stock P - Purchase I 17,0000 400.000 6.800 3.241.628
2020-07-28 2020-07-28 4 Bain Capital Life Sciences Investors, LLC See Footnotes ANNX Common Stock C - Conversion I 319.243 2.841.628
2020-07-28 2020-07-28 4 Bain Capital Life Sciences Investors, LLC See Footnotes ANNX Common Stock C - Conversion I 2.522.385 2.522.385
2020-07-24 2020-07-23 4 Overdorf Michael ANNX Stock Option (Right to Buy) A - Award D 17,00 242.905 242.905
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista